Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2020 Oct 7;163(3):853–860.e2. doi: 10.1016/j.jtcvs.2020.09.097

Table 3.

Recipient cause of death among those with cause of death documented stratified by length of survival post-transplant

Cause of death <1 year survival 1–10 year survival >10 year survival
(n=911) (n=2,639) (n=337)
Graft failure 139 (15.3%) 539 (20.4%) 54 (16.0%)
Pulmonary 122 (13.4%) 491 (18.6%) 40 (14.8%)
Cardiovascular 72 (7.9%) 148 (5.6%) 22 (6.5%)
Infection 288 (31.6%) 412 (15.6%) 39 (11.6%)
Malignancy 30 (3.3%) 389 (14.7%) 65 (19.3%)
Renal failure 3 (0.3%) 58 (2.2%) 9 (2.7%)
Liver failure 5 (0.5%) 18 (0.7%) 3 (0.9%)
Multiple organ failure 82 (9.0%) 87 (3.3%) 9 (2.7%)
Other 170 (18.7%) 497 (18.8%) 86 (25.5%)